Top

Published in:

01-06-2008 | Gastrointestinal Oncology

Clinicopathological Features and Surgical Outcomes of Patients with Remnant Gastric Cancer after a Distal Gastrectomy

Authors: Hye Seong Ahn, MD, Jong Won Kim, MD, Moon-Won Yoo, MD, Do Joong Park, MD, PhD, Hyuk-Joon Lee, MD, PhD, Kuhn Uk Lee, MD, FACS, Han-Kwang Yang, MD, PhD

Published in: Annals of Surgical Oncology | Issue 6/2008

Abstract

Background

The incidence of gastric cancer in the remnant stomach after distal gastrectomy is increasing. The aim of this study was to evaluate the clinicopathological features and surgical outcomes of remnant gastric cancer (RGC).

Methods

We reviewed the medical records of 58 patients who underwent laparotomy for RGC at Seoul National University Hospital between 2000 and 2005.

Results

The mean interval between the first and second operations was 12.5 years, and the rate of RGC diagnosis by tests included the follow-up program was 41.4%. The 45 RGCs occurring after distal gastrectomy for initial gastric cancer had a shorter interval and were more frequently located at the non-anastomotic site than those following benign lesions (P <0.001 and P = 0.010). Of all patients, 41 (70.7%) underwent, and the overall 3-year survival rate was 62.4%. An early stage of the initial gastric cancer, no symptoms at diagnosis, curative resection, tumor size smaller than 6 cm, and an early TNM stage of the RGC were associated with longer survival; the initial gastric disease, the interval and the location of RGC were not.

Conclusion

The successful curative resection and an early stage of the RGC led to good outcomes. In considering the different latency periods of the two initial gastric diseases, appropriate follow-up programs should be developed.

Guadagni S, Reed PI, Johnston BJ, et al. Early gastric cancer: follow-up after gastrectomy in 159 patients. Br J Surg 1993; 80:325–8PubMedCrossRef

Ikeguchi M, Kondou A, Shibata S, Yamashiro H, et al. Clinicopathologic differences between carcinoma in the gastric remnant stump after distal partial gastrectomy for benign gastroduodenal lesions and primary carcinoma in the upper third of the stomach. Cancer 1994; 73:15–21PubMedCrossRef

Balfour DC. Factors influencing the life expectancy of patients operated on for gastric cancer. Ann Surg 1922; 76:405–8PubMedCrossRef

Thorban S, Bottcher K, Etter M, et al. Prognostic factors in gastric stump carcinoma. Ann Surg 2000; 231:188–94PubMedCrossRef

Furukawa H, Iwanaga T, Hiratsuka M, et al. Gastric remnant cancer as a metachronous multiple lesion. Br J Surg 1993; 80:54–6PubMedCrossRef

Kodera Y, Yamamura Y, Torii A, et al. Gastric remnant carcinoma after partial gastrectomy for benign and malignant gastric lesions. J Am Coll Surg 1996; 182:1–6PubMed

Inomata M, Shiraishi N, Adachi Y, et al. Gastric remnant cancer compared with primary proximal gastric cancer. Hepatogastroenterology 2003; 50:587–91PubMed

Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma - 2nd English Edition. Gastric Cancer 1998; 1:10–24

Ohashi M, Katai H, Fukagawa T, et al. Cancer of the gastric stump following distal gastrectomy for cancer. Br J Surg 2007; 94:92–5PubMedCrossRef

10.

Kaneko K, Kondo H, Saito D, et al. Early gastric stump cancer following distal gastrectomy. Gut 1998; 43:342–4PubMedCrossRef

11.

Kodera Y, Yamamura Y, Torii A, et al. Gastric stump carcinoma after partial gastrectomy for benign gastric lesion: what is feasible as standard surgical treatment? J Surg Oncol 1996; 63:119–124PubMedCrossRef

12.

Sasako M, Maruyama K, Kinoshita T, et al. Surgical treatment of carcinoma of the gastric stump. Br J Surg 1991; 78:822–824PubMedCrossRef

13.

Newman E, Brennan MF, Hochwald SN, Harrison LE, Karpeh MS Jr. Gastric remnant carcinoma: just another proximal gastric cancer or a unique entity? Am J Surg 1997; 173:292–7PubMedCrossRef

14.

Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965; 64:31–49PubMed

15.

Sobin LH, Wittekind C. (eds). TNM classification of malignant tumors(6th Edition), 2002

16.

Kunisaki C, Shimada H, Nomura M, et al. Lymph node dissection in surgical treatment for remnant stomach cancer. Hepatogastroenterology 2002; 49:580–4PubMed

17.

Isozaki H, Tanaka N, Fujii K, et al. Surgical treatment for advanced carcinoma of the gastric remnant. Hepatogastroenterology 1998; 45:1896–900PubMed

18.

Lissens P, Filez L, Aerts R, et al. Surgery for gastric remnant carcinoma following Billroth II gastrectomy. Eur J Surg Oncol 1997; 23:518–21PubMedCrossRef

19.

Piso P, Meyer HJ, Edris C, et al. Surgical therapy of gastric stump carcinoma–a retrospective analysis of 109 patients. Hepatogastroenterology 1999; 46:2643–7PubMed

20.

Park DJ, Lee HJ, Kim HH, et al. Predictors of operative morbidity and mortality in gastric cancer surgery. Br J Surg 2005; 92:1099–102PubMedCrossRef

21.

Sinning C, Schaefer N, Standop J, et al. Gastric stump carcinoma - Epidemiology and current concepts in pathogenesis and treatment. Eur J Surg Oncol 2007; 33:133–9PubMedCrossRef

22.

Mason RC, Taylor PR, Folipe MI, McColl I. Pancreaticoduodenal secretions and the genesis of gastric stump carcinoma in the rat. Gut 1988; 29:830–4PubMedCrossRef

23.

Nishidoi H, Koga S, Kaibara N. Possible role of duodenogastric reflux on the development of remnant gastric carcinoma induced by N-methyl-N’-nitro-N-nitroso-guanidine in rats. Journal of National Cancer Institute 1984; 72:1431–5

24.

Lee HJ, Yang HK, Ahn YO. Gastric cancer in Korea. Gastric Cancer 2002; 5:177–82PubMedCrossRef

25.

Kodera Y, Yamamura Y, Torii A, Uesaka K, et al. Incidence, diagnosis and significance of multiple gastric cancer. Br J Surg 1995; 82:1540–3PubMedCrossRef

26.

Bozzetti F, Marubini E, Bonfanti G, et al. Total versus subtotal gastrectomy: surgical morbidity and mortality rates in a multicenter Italian randomized trial. The Italian Gastrointestinal Tumor Study Group. Ann Surg 1997; 226:613–20PubMedCrossRef

27.

Bozzetti F, Marubini E, Bonfanti G, et al. Subtotal versus total gastrectomy for gastric cancer: five-year survival rates in a multicenter randomized Italian trial. Italian Gastrointestinal Tumor Study Group. Ann Surg 1999; 230:170–8PubMedCrossRef

28.

De Manzoni G, Verlato G, Roviello F, et al. Subtotal versus total gastrectomy for T3 adenocarcinoma of the antrum. Gastric Cancer 2003; 6:237–42PubMedCrossRef

29.

Robertson CS, Chung SC, Woods SD, et al. A prospective randomized trial comparing R1 subtotal gastrectomy with R3 total gastrectomy for antral cancer. Ann Surg 1994; 220:176–82PubMedCrossRef

30.

Takeno S, Noguchi T, Kimura Y, et al. Early and late gastric cancer arising in the remnant stomach after distal gastrectomy. Eur J Surg Oncol 2006; 32:1191–4PubMedCrossRef

31.

Bohner H, Zimmer T, Hopfenmuller W, Berger G, et al. Detection and prognosis of recurrent gastric cancer–is routine follow-up after gastrectomy worthwhile? Hepatogastroenterology 2000; 47:1489–94PubMed

32.

Kodera Y, Ito S, Yamamura Y, et al. Follow-up surveillance for recurrence after curative gastric cancer surgery lacks survival benefit. Ann Surg Oncol 2003; 10:898–902PubMedCrossRef

Title: Clinicopathological Features and Surgical Outcomes of Patients with Remnant Gastric Cancer after a Distal Gastrectomy
Authors: Hye Seong Ahn, MD
Jong Won Kim, MD
Moon-Won Yoo, MD
Do Joong Park, MD, PhD
Hyuk-Joon Lee, MD, PhD
Kuhn Uk Lee, MD, FACS
Han-Kwang Yang, MD, PhD
Publication date: 01-06-2008
Publisher: Springer-Verlag
Published in: Annals of Surgical Oncology / Issue 6/2008
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI: https://doi.org/10.1245/s10434-008-9871-8

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Clinicopathological Features and Surgical Outcomes of Patients with Remnant Gastric Cancer after a Distal Gastrectomy

Abstract

Background

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 6/2008

Radiofrequency Ablation versus Resection for Resectable Colorectal Liver Metastases: Time for a Randomized Trial?

Appropriate Treatment for Patients with Gastric Adenocarcinoma

Compound Muscle Action Potentials and Spontaneous Electromyography Can be Used to Identify and Protect the Femoral Nerve During Resection of Large Retroperitoneal Tumors

Soluble Intercellular Adhesion Molecule-1 as a Prognostic Marker for Stage II Colorectal Cancer Patients

A Systematic Review of Radiofrequency Ablation for Lung Tumors

HER2-Positive Early Breast Cancer and Trastuzumab: A Surgeon’s Perspective